Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes

被引：0
|
作者：
Vaia Lambadiari
George Pavlidis
Foteini Kousathana
Maria Varoudi
Dimitrios Vlastos
Eirini Maratou
Dimitrios Georgiou
Ioanna Andreadou
John Parissis
Helen Triantafyllidi
John Lekakis
Efstathios Iliodromitis
George Dimitriadis
Ignatios Ikonomidis
机构：
[1] Attikon University Hospital,2nd Department of Internal Medicine, Research Unit and Diabetes Center
[2] National and Kapodistrian University of Athens,2nd Cardiology Department
[3] Medical School,Department of Pharmaceutical Chemistry, School of Pharmacy
[4] Attikon Hospital,undefined
[5] National and Kapodistrian University of Athens,undefined
[6] Medical School,undefined
[7] Hellenic National Center for the Prevention of Diabetes and Its Complications HNDC,undefined
[8] National and Kapodistrian University of Athens,undefined
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Arterial stiffness; Augmentation index; Glp-1 analogue; Liraglutide; Metformin; Left ventricular function; Oxidative stress;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 39 条
  • [21] Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes
    Kaku, K.
    Rasmussen, M. F.
    Clauson, P.
    Seino, Y.
    DIABETES OBESITY & METABOLISM, 2010, 12 (04): : 341 - 347
  • [22] Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus
    Yan, Pijun
    Li, Ling
    Yang, Mengliu
    Liu, Dongfang
    Liu, Hua
    Boden, Guenther
    Yang, Gangyi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (03) : 368 - 374
  • [23] Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
    Rebekka Faber
    Mette Zander
    Adam Pena
    Marie M Michelsen
    Naja D Mygind
    Eva Prescott
    Cardiovascular Diabetology, 14
  • [24] Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study
    Faber, Rebekka
    Zander, Mette
    Pena, Adam
    Michelsen, Marie M.
    Mygind, Naja D.
    Prescott, Eva
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [25] Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Nozue, Tsuyoshi
    Yamada, Masayo
    Tsunoda, Tetsuji
    Katoh, Hiromasa
    Ito, Shimpei
    Iwaki, Taku
    Michishita, Ichiro
    HEART AND VESSELS, 2016, 31 (08) : 1239 - 1246
  • [26] Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Tsuyoshi Nozue
    Masayo Yamada
    Tetsuji Tsunoda
    Hiromasa Katoh
    Shimpei Ito
    Taku Iwaki
    Ichiro Michishita
    Heart and Vessels, 2016, 31 : 1239 - 1246
  • [27] Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
    Kim, Jin Hee
    Lee, Gha Young
    Maeng, Hyo Jin
    Kim, Hoyoun
    Bae, Jae Hyun
    Kim, Kyoung Min
    Lim, Soo
    ENDOCRINOLOGY AND METABOLISM, 2021, 36 (01) : 157 - 170
  • [28] Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials
    Davidson, J. A.
    Orsted, D. D.
    Campos, C.
    DIABETES OBESITY & METABOLISM, 2016, 18 (07): : 725 - 728
  • [29] Population Pharmacokinetics of Liraglutide, a Once-Daily Human Glucagon-Like Peptide-1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice-Daily Exenatide
    Watson, Estelle
    Jonker, Daniel M.
    Jacobsen, Lisbeth V.
    Ingwersen, Steen H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08): : 886 - 894
  • [30] Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects
    Sloan, Lance A.
    JOURNAL OF DIABETES, 2019, 11 (12) : 938 - 948
1234